191 related articles for article (PubMed ID: 37930439)
21. Identification of hub anoikis-associated genes and risk signature in cutaneous melanoma.
He YW; Fan QP; Hua AL; Liu Q
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5662-5676. PubMed ID: 37401304
[TBL] [Abstract][Full Text] [Related]
22. System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma.
Zhao S; Zhu Y; Liu H; He X; Xie J
J Transl Med; 2023 Nov; 21(1):801. PubMed ID: 37950289
[TBL] [Abstract][Full Text] [Related]
23. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
24. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma.
Xie Y; Xu Z; Mei X; Shi W
Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905
[TBL] [Abstract][Full Text] [Related]
25. Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma.
Cen X; Li M; Yao A; Zheng Y; Lai W
J Gene Med; 2024 Jan; 26(1):e3614. PubMed ID: 37847069
[TBL] [Abstract][Full Text] [Related]
26. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
27. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
[TBL] [Abstract][Full Text] [Related]
28. Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients.
Liao S; He J; Liu C; Zhang Z; Liao H; Liao Z; Yu C; Guan J; Mo H; Yuan Z; Liang T; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2021 Jun; 100(22):e26219. PubMed ID: 34087900
[TBL] [Abstract][Full Text] [Related]
29. Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation.
Guo W; Zhao G; Liu S; Deng T; Zhang G; Zhang B
J Gene Med; 2023 Sep; 25(9):e3534. PubMed ID: 37259225
[TBL] [Abstract][Full Text] [Related]
30. Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma.
Song B; Wang K; Peng Y; Zhu Y; Cui Z; Chen L; Yu Z; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18135-18160. PubMed ID: 38006451
[TBL] [Abstract][Full Text] [Related]
31. TREM2 as a Potential Immune-Related Biomarker of Prognosis in Patients with Skin Cutaneous Melanoma Microenvironment.
Zhu X; Zeng Z; Chen M; Chen X; Hu D; Jiang W; Du M; Chen T; Chen T; Liao W; Zhang C; Qu Y; Pan W
Dis Markers; 2023; 2023():8101837. PubMed ID: 36741909
[TBL] [Abstract][Full Text] [Related]
32. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.
Liang Z; Pan L; Shi J; Zhang L
Sci Rep; 2022 Nov; 12(1):20460. PubMed ID: 36443341
[TBL] [Abstract][Full Text] [Related]
33. Identification of the ageing-related prognostic gene signature, and the associated regulation axis in skin cutaneous melanoma.
Tian C; Liu S; Huo R
Sci Rep; 2023 Jan; 13(1):24. PubMed ID: 36631465
[TBL] [Abstract][Full Text] [Related]
34. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
[TBL] [Abstract][Full Text] [Related]
35. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
36. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
Liu Y; Shi Z; Zheng J; Zheng Z; Sun H; Xuan Z; Bai Y; Fu M; Du Y; Shao C
Front Immunol; 2023; 14():1171883. PubMed ID: 37056778
[TBL] [Abstract][Full Text] [Related]
37. The evaluation of tumor microenvironment infiltration and the identification of angiogenesis-related subgroups in skin cutaneous melanoma.
Li J; Ren H; Huai H; Li J; Xie P; Li X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7259-7273. PubMed ID: 36912943
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma.
Li AA; Zhang Y; Tong WL; Chen JW; Huang SH; Liu JM; Liu ZL
Int J Gen Med; 2022; 15():6145-6163. PubMed ID: 35855761
[TBL] [Abstract][Full Text] [Related]
39. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
[TBL] [Abstract][Full Text] [Related]
40. Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer.
Li C; Weng J; Yang L; Gong H; Liu Z
Front Immunol; 2024; 15():1378305. PubMed ID: 38779664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
